Tech Company Financing Transactions
Greenbrook TMS Funding Round
Greenbrook TMS closed a $8.3 million funding round on 3/24/2023. Investors included Madryn Asset Management, Greybrook Realty Partners and Masters Capital Management.
Transaction Overview
Company Name
Announced On
3/24/2023
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$8,250,000
Round
Undisclosed
Investors
Proceeds Purpose
The Company intends to use the proceeds from the Private Placement for the development of new mental health service centers that specialize in Transcranial Magnetic Stimulation ("TMS") treatment as well as working capital and general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
890 Yonge Street 7th Fl 120
Toronto, Ontario, M4W 3P4
CA
Toronto, Ontario, M4W 3P4
CA
Phone
Website
Email Address
Overview
Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Leonard
Chief Financial Officer
Erns Loubser
Chief Marketing Officer
Euphia Smith
Chief Medical Officer
Geoffrey Grammer
Chief Operating Officer
Benjamin Klein
Browse more venture capital transactions:
Prev: 3/24/2023: Unikraft venture capital transaction
Next: 3/24/2023: Dylibso venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs